Agile Therapeutics Inc (NASDAQ:AGRX)

0.2026
Delayed Data
As of Dec 02
 +0.0026 / +1.30%
Today’s Change
0.18
Today|||52-Week Range
29.60
-98.96%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Agile Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +393.58% increase from the last price of 0.20.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Agile Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$3.1M
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 56.60%
 
 
 
 
 
Growthannually 91.88%
 
 
 
 
 
 

Sales

Growthquarterly 2.76%
 
 
 
 
 
 
Growthannually 143.21%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.